ArticleEClinicalMedicine2025

Impact of platinum-based chemotherapy and CTLA-4 inhibition on acquired resistance to first-line anti-PD-1/PD-L1 agents in non-small cell lung cancer: a systematic review and reconstructed individual patient data analysis.

Sara Oresti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.